ROBIN D BYRNE

Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family SWEETWATER, TX NPI 1124491634

General Payments — all program years on this page

$378.41

  • Category: General Payments
  • Program years: PY2021–2024
  • Record count: 22
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $282.16 across 16 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $282.1616

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Acerta Pharma LLC $141.498
Novo Nordisk AS $110.376
Exact Sciences Corporation $15.541
Lilly USA, LLC $14.761

By program year

Program yearAmountRecords
2021 $11.291
2022 $19.881
2023 $65.084
2024 $282.1616

Records — PY2024 (16)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1100253844 Novo Nordisk Inc $27.98 11/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100293616 Novo Nordisk Inc $17.25 02/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100321776 Novo Nordisk Inc $15.35 04/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100378279 Novo Nordisk Inc $13.08 10/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100534553 Novo Nordisk Inc $15.30 09/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100537367 Novo Nordisk Inc $21.41 07/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104237629 AstraZeneca Pharmaceuticals LP $23.75 04/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104503360 AstraZeneca Pharmaceuticals LP $17.65 01/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104583612 AstraZeneca Pharmaceuticals LP $16.07 11/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104699119 AstraZeneca Pharmaceuticals LP $21.17 11/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105581862 AstraZeneca Pharmaceuticals LP $16.54 05/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105665250 AstraZeneca Pharmaceuticals LP $14.34 10/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105697918 AstraZeneca Pharmaceuticals LP $18.42 02/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105714656 AstraZeneca Pharmaceuticals LP $13.55 04/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114438962 Exact Sciences Corporation $15.54 08/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135882453 Lilly USA, LLC $14.76 03/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.